Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

AI model turns POCUS images into accurate structural heart evaluations
Researchers see potential for this technology to make cardiac screening much easier for physicians who are not trained cardiologists.
Microsoft and Bristol Myers Squibb partner to advance AI-enabled lung cancer detection
Lung cancer remains the leading cause of cancer-related deaths in the United States. It is estimated that it claims approximately 125,000 lives in the U.S. every year.
FDA clears opportunistic AI for detecting cardiothoracic issues in CT scans
“Coronary calcium revealed long ago that atherosclerosis begins well before symptoms. AI-CVD extends that insight by enabling systematic identification of patients who are unaware of their cardiovascular risk using CT scans that already exist,” said Arthur Agatston, MD.
CT colonography the most cost-effective cancer screening option for many
Findings from the Neiman Health Policy Institute and Northwell Health indicate that CTC is especially beneficial for underserved populations.
Beyond just nodules—model uses all low-dose CT data to make long-term lung cancer risk predictions
New findings published in RSNA's Radiology highlight the shortcomings of using nodule characteristics and patient history alone to predict an individual’s true cancer risk.

Continued declines in screening mammogram volumes could have 'worrisome implications,' experts warn

The downward trend is most notable in women who have at least one risk factor of severe COVID, new data suggest.

Considerations for supplemental imaging should extend beyond breast density, analysis suggests

Women with increased breast density are targeted significantly more for supplemental imaging than those without dense tissue, but there are other factors that increase the risk of mammography screening failure that should also be considered, according to new data.

Two examples of PSMA-PET scans showing numerous prostate cancer metastases spread throughout the body. Many of these smaller tumors would not have been dected on previous standard-of-care imaging. Photo on left courtesy of SNMMI, right University of Chicago. #PSMAPET

PSMA-PET a more cost-effective option for patients long-term compared to standard prostate imaging

The findings support adopting F-18 DCFPyL PET/CT as the standard of care for prostate cancer staging, authors of a new Scientific Reports paper concluded.

Experts cite 'urgent need' for changes to USPSTF breast cancer screening recommendations

The USPSTF’s update suggests that women should screen every other year, but the group's own modeling studies have cited the benefits of annual screening.

Katie Couric on USPSTF recommendations on when women should start getting mammograms

'Kind of a bummer': Katie Couric disappointed in USPSTF recs that exclude supplementary imaging for dense breasts

The task force cited insufficient evidence as the driver behind the decision to forego recommending supplemental screening.

Nearly 90% of significant incidental findings on lung cancer screenings are considered reportable

These findings highlight a need for more stringent and standardized reporting guidelines relative to incidental findings, authors of the new study suggested.

How 'mindlessly' following AI guidance impacts radiologist performance

Radiologists interpreting screening mammograms may be especially susceptible to falling victim to automation bias, as these exams are repetitive in nature.

Breast cancer risk assessments should account for longitudinal changes in breast density, new data suggest

Breast density is known to drop over time, but the rate at which density decreases merits special attention, as it could be associated with a woman’s chance of developing cancer.

Screening

AI model turns POCUS images into accurate structural heart evaluations

Microsoft and Bristol Myers Squibb partner to advance AI-enabled lung cancer detection

FDA clears opportunistic AI for detecting cardiothoracic issues in CT scans

CT colonography the most cost-effective cancer screening option for many

Beyond just nodules—model uses all low-dose CT data to make long-term lung cancer risk predictions